InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,572.85
(
0.10%
)
US TECH 100
19,942.40
(
0.48%
)
Dow Jones
39,344.79
(
-0.08%
)
Brent Oil
85.42
(
-1.26%
)
Bitcoin
56,691.54
(
1.51%
)
Post# of 346054
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

atonewith PPHM

Send PM Follow Ignore
Followers 12
Posts 890
Boards Moderated 0
Alias Born 06/17/2011

atonewith PPHM

Re: None

Tuesday, 07/29/2014 9:11:12 AM

Tuesday, July 29, 2014 9:11:12 AM

Post# of 346054
Yervoy/Bavi trial started on April 23rd. The protocol was biopsy and blood work at start, 3 weeks in more testing and at the 15 week mark more testing.
We are now 2 1/2 weeks shy of the 15 week mark. If some patients were dosed at the 4/23 start date we will start to get an idea of what is happening with more data following on each new patient as they cycle.
Based of Dr. Brekken's comments, "as much as 200-300% improvement in response" things should get very interesting and probably soon.
Any company with a SOC drug in use is in danger of being bumped by a competitor using Bavi or being guaranteed their position with the addition of Bavi. Not a hard choice in my opinion!
Strong Buy/Buying Opportunity! IMHO
AtonewithPPHM
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent CDMO News
More CDMO News
InvestorsHub NewsWire

Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM

Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM

EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM

BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM

NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM

Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM

Start posting your company's news
Only $200 per official company press release!